A novel instrument for detecting cancer cells in the blood could lead to individualized cancer treatments for patients suffering metastasis. Developed by a Massachusetts General Hospital team led by Daniel Haber, M.D., Ph.D., a renowned cancer scientists supported by the National Foundation for Cancer Research since 2003, the business card-sized…...
Viagra: A Colon Cancer Risk Mitigator?
Researchers at the Georgia Cancer Center and Department of Biochemistry and Molecular Biology at the Medical College of Georgia at Augusta University found that a small, daily dose of Viagra significantly reduces colorectal cancer risk. While mortality from colorectal cancer continues to fall, it remains the third-leading cause of cancer…...
Giving for Good—Donating IRA, Stock & Other Financial Assets
There are many creative ways to generously support the National Foundation for Cancer Research (NFCR) while too accounting for what’s best for your family. Your gift can take multiple forms and can help you address your personal financial goals. Let’s, in simple English, dive a bit into some of these…...
Liver Cancer: A Primer
With October being recognized as Liver Cancer Awareness Month, the National Foundation for Cancer Research (NFCR) presents to you a quick overview of the disease—and too insight into the importance of early detection and recent advances to that end. According to a July 2018 report from the U.S. Centers for…...
Introducing: Faces & Voices of Cancer
You’ve been touched by cancer. We all have been. Maybe you’re a patient, caregiver, researcher, donor or survivor. Maybe you’ve even lost a loved one. Now it’s time to raise your voice. Tell your story. Inspire. And remind others—and even yourself—that none of us are alone. On Friday, October 12th,…...
Strategic Media Partner
